We have previously proven that the interspecies incompatibility of CD47 is responsible for in vitro phagocytosis of xenogeneic cells by host macrophages. Utilizing an in vivo model in the present study, we investigated whether genetically engineered expression of mouse CD47 in rat insulinoma cells (INS-1E) could inhibit macrophage-mediated xenograft rejection. INS-1E cells transfected with the pRc/CMV-mouse CD47 vector (mCD47-INS-1E) induced SIRPa-tyrosine phosphorylation in mouse macrophages in vitro, whereas cells transfected with the control vector (cont-INS-1E) did not. When these cells were injected into the peritoneal cavity of streptozotocin-induced diabetic Rag2 2/2 c chain 2/2 mice, which lack T, B, and NK cells, the expression of mouse CD47 on the INS-1E cells markedly reduced the susceptibility of these cells to phagocytosis by macrophages. Moreover, these mice became normoglycemic after receiving mCD47-INS-1E, whereas the mice that received cont-INS-1E failed to achieve normoglycemia. Furthermore, injection of an anti-mouse SIRPa blocking monoclonal antibody into the mouse recipients of mCD47-INS-1E cells prevented achievement of normoglycemia. These results demonstrate that interspecies incompatibility of CD47 significantly contributes to in vivo rejection of xenogeneic cells by macrophages. Thus, genetic induction of the expression of recipient CD47 on xenogeneic donor cells could provide inhibitory signals to recipient macrophages via SIPRa; this constitutes a novel approach for preventing macrophage-mediated xenograft rejection.
Introduction
Xenotransplantation, using organs, tissues, and cells from other species as the transplant source, has the potential to resolve the severe shortage of human donors; however, robust immune responses to xenografts remain a major obstacle to the clinical application of this approach [1, 2] . Extensive genetic disparities between the donor and recipient are thought to contribute significantly to the more vigorous rejection of xenografts than allografts; these disparities, however, remain ill-defined. Vigorous innate immune cell activation can be accounted for by both recognition of xenoantigens by activating receptors, and an incompatibility in inhibitory receptor-ligand interactions [3] .
In human xenograft recipients, innate humoral and cellular xenoimmune responses are both predominantly elicited by preformed and induced xenoreactive antibodies (Abs). Among the components of innate immunity, macrophages, which can be activated by prophagocytic signaling pathways through Fcc receptors, play a significant role in targeting xenogeneic cells that have been opsonized with these Abs. Genetically engineered a-1,3-galactosyltransferase (GalT)-knockout pigs, which no longer express the major xenoantigens Gala1,3Galb1,4GlcNAc (Gal) carbohydrate residues held promise for conferring protection against such xenoreactive Ab-mediated rejection [4] [5] [6] .
However, we have previously demonstrated that human reticuloendothelial macrophages can phagocytose porcine cells even in the absence of Ab or complement opsonization, and that removing Gal epitopes from porcine cells failed to prevent this phagocytosis [7] . Similarly, other groups have also reported that non-human primate macrophages mediate rapid rejection of porcine pancreatic islets [8] , which express little or no Gal antigens [9] . These results suggest that regulation of macrophages in human recipients may be required to achieve successful engraftment of porcine xenografts.
We have recently proven that the interspecies incompatibility of CD47 is responsible for in vitro phagocytosis of xenogeneic porcine cells by human macrophages [10] . CD47 is an ubiquitously expressed cell surface protein of the immunoglobulin superfamily that serves as a ligand for signal regulatory protein (SIRP) a, an immune inhibitory receptor on macrophages. CD47 and SIRPa constitute a cell-cell communication system (the CD47-SIRPa system); such interactions play important roles in both hematopoietic and immunological regulation [11] [12] [13] [14] . In addition, the CD47-SIRPa system has been implicated in negative regulation of phagocytosis by macrophages [15] ; specifically, when expressed on the surface of several cell types (i.e., erythrocytes, platelets, or leukocytes), CD47 can protect against phagocytosis by macrophages by binding to SIRPa [15] . Moreover, CD47 inhibits both Fcc and complement receptor-mediated phagocytosis through its SIRPa receptors [16] .
We have previously verified that porcine CD47 does not induce tyrosine phosphorylation of SIRPa in human macrophages, and that manipulation of porcine cells for expression of human CD47 markedly reduces the susceptibility of these cells to phagocytosis by human macrophages in vitro [10] . These results indicated that genetic induction of the expression of recipient-type CD47 on xenogeneic donor cells could provide inhibitory signaling to SIPRa on host macrophages, suggesting a novel approach for preventing macrophage-mediated xenograft rejection.
Here, we have now investigated this postulate in a rat-to-mouse in vivo model, in which the interspecies incompatibility of CD47 (85% amino acid sequence homology between these species [17] ) would normally cause active phagocytosis of rat cells by mouse macrophages.
Materials and Methods

Antibodies
An anti-SIRPa Ab (P84) was used to block the macrophage inhibitory receptor, SIRPa [18] . Biotin-conjugated rat anti-mouse CD11b (M1/70; BD Pharmingen, San Diego, CA, USA), purified anti-mouse CD47 Ab (miap301; BD Pharmingen), and APC Streptavidin (BD Pharmingen) were used for FACS analysis via immunofluorescence using a FACSCaliburH (BD Biosciences, Franklin Lakes, NJ, USA). In FACS analyses, nonspecific binding of labeled mAbs was blocked with rat anti-mouse FCcR mAb, 2.4G2. Rabbit polyclonal Ab against SIRPa (Abcam, La Jolla, CA, USA), purified rat anti-mouse CD172a (P84) Ab (BD Pharmingen), purified rabbit polyclonal anti-phosphotyrosine Ab (BD Transduction Laboratories, Lexington, KY, USA), and horse radish peroxidase (HRP)-conjugated rabbit secondary Ab (Amersham Biosciences Co., Piscataway, NJ, USA) were used for immunoprecipitation and western blot analysis.
Cell Cultures
All cells were maintained at 37uC under a humidified atmosphere of 5% CO2 in air. A rat insulinoma cell line (INS-1E) [19] was kindly provided by Dr. Claes B. Wollheim (University of Geneva, Switzerland). Cells were cultured in RPMI1640 containing 10% FCS with 5 mM 2-mercaptoethanol (2-ME; Katayama, Osaka, Japan), 10% HEPES buffer (Gibco, NY, USA), and 100 IU/mL penicillin-100 mg/mL streptomycin (Gibco). P84 hybridoma cells producing an anti-SIRPa Ab were kindly provided by T. Matozaki (Gunma University, Gunma, Japan). The mouse macrophages were cultured in DMEM containing 10% FCS with 5 mM 2-ME, 10% HEPES buffer, and 100 IU/mL penicillin-100 mg/mL streptomycin.
Animals
Rag2
2/2 c chain 2/2 mice were purchased from Taconic (One Hudson City Centre Hudson, NY, USA). All animal protocols described in this study were performed in accordance with the Guide for the Care and Use of Laboratory Animals and the local committee for animal experiments, and the experimental protocol was approved by the Ethics Review Committee for Animal Experimentation of the Graduate School of Biomedical Sciences, Hiroshima University.
Mouse Macrophage Preparation
To prepare peritoneal macrophages, peritoneal cells were harvested from B6 mice after intraperitoneal injection of PBS, plated in a Gelatin Cellware 75-cm2 Vented Flask (BD Biosciences) and cultured at 37uC for 2 h. Macrophages were used after non-adherent cells were washed off.
T Cell Isolation
T cells were negatively isolated from wild type B6 splenocytes using a cocktail of biotin-conjugated monoclonal antibodies against CD11b, CD11c, CD19, CD45R (B220), CD49b (DX5), CD105, anti-MHC class II, and Ter-119 and anti-biotin antibodycoated magnetic beads (Miltenyi Biotec, Bergisch Gladbach, Germany) according to the manufacturer's instructions. The purity of T cells was $95% (data not shown), as determined by CD3e surface staining using FACS analysis.
Immunoprecipitation and Immunoblotting
Peritoneal macrophages (26106) were incubated for 16 h before experiments and rinsed once with PBS. Then, 26107 mouse or rat RBCs or INS-1E cells were added to the macrophage cultures, and incubated at 37uC for 30 min. The cells were lysed in 0.3 mL of lysis buffer [1% NP-40, 1 mM PMSF, 50 mM bglycophosphate, 20 mM NaF, 0.5 mg/mL leupeptin, 0.5 mg/mL aprotinin, and 2 mM sodium pervanadate] by rotation on ice for 15 min.
For immunoprecipitation, the lysates were mixed with rat antimouse SIRPa Ab (P84) and 50% slurry of protein G-sepharose beads (Sigma-Aldrich, St. Louis, MO, USA) by rotation at 4uC for 8 h. Precipitated proteins were separated by 8% SDS-PAGE and transferred to nitrocellulose membrane. Thereafter, polyclonal rabbit anti-phosphotyrosine Ab (BD Pharmingen) and HRP-linked anti-rabbit IgG Ab (Amersham Biosciences Co.) were used as primary and secondary Abs, respectively, in western blot analysis. Alternatively, the membrane was stained with rabbit polyclonal Ab against SIRPa (Abcam), followed by HRP-linked anti-rabbit IgG Ab (Amersham Biosciences Co.). 
Mouse CD47 cDNA Plasmid Construction and Transfection
The entire coding region of the CD47 cDNA was PCRamplified from reverse-transcribed mouse lymphocyte cDNA with primers (sense) 59-GCGAAGTGACAGAGTTATCC-39 and (antisense) 59-TGGCTCACATGCCATGATGC-39. The amplified PCR product was digested with EcoRI/NotI and cloned into the pRc/CMV vector (kindly provided by Dr. Tadashi Furusawa, National Institute of Animal Research Industry, Japan), which had been predigested with the same restriction endonucleases. Rat insulinoma cells (INS-1E) were transfected with either pRc/CMVmouse CD47 or the empty plasmid, using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). Five hours after the transfection, cells were selected with G418 (Sigma-Aldrich; 800 mg/mL) for 1 week to generate stable cell lines and analyzed for expression of mouse CD47 by FACS analyses.
Diabetic Mice Generation
Rag2
2/2 c chain 2/2 mice were rendered diabetic through a single i.p. administration of 200 mg/kg streptozotocin (SigmaAldrich) at 6 days prior to injection of rat INS-1E cells. Diabetic mice with non-fasting blood glucose levels of .400 mg/dL on the day of transplantation were used as the recipients. The blood glucose levels were monitored with a blood glucose test meter (Medisafemini GR-102; Terumo, Somerset, NJ, USA). In the absence of INS-1E cell transplantation, diabetes persisted in all diabetic mice (blood glucose level: 0.350 mg/dL), and no spontaneous reversal of diabetes was observed for at least the next 3 months.
In vivo Phagocytic Assay
Target cells were stained with the fluorescent dye 5/6-CFSE (Molecular Probes, Eugene, OR, USA) according to the manufacturer's protocol. Either CFSE-labeled mCD47-INS-1E cells (10610 6 ) or cont-INS-1E cells (10610 6 ) were injected into the peritoneal cavity of streptozotocin-induced diabetic Rag2 2/2 c chain 2/2 mice. After 6 h, the recipient intraperitoneal cells were harvested and the macrophages that phagocytosed the target cells could be identified by FACS analysis, based on CFSE labeling.
Statistical analysis. Significant differences between groups were determined using Student's t-test. A p-value of ,0.05 was considered statistically significant.
Results
Rat CD47 does not Induce Tyrosine Phosphorylation of SIRPa in Mouse Macrophages
In the CD47-SIRP system, the interaction between SIRP, on macrophages, and CD47, on target cells, inhibits phagocytosis of the target cells by promoting phosphorylation of tyrosine in the cytoplasmic domain, and recruitment of Src homology 2 domaincontaining protein tyrosine phosphatase-1, which is the major regulator of phagocytic responses [20] .
To determine whether rat CD47 can interact with mouse SIRPa, we assessed tyrosine phosphorylation of SIRPa in mouse macrophages after contact with either rat or mouse RBCs. Western blotting revealed that incubation of mouse peritoneal cavity macrophages with mouse RBCs resulted in SIRPa tyrosine phosphorylation, as expected (Fig. 1) . However, after incubation with rat RBCs, this tyrosine phosphorylation was not induced in mouse macrophages above the level in control macrophages, which had been incubated with medium alone, indicating that rat CD47 fails to induce SIRPa tyrosine phosphorylation in mouse macrophages.
Mouse CD47 Expression on Rat Cells Markedly Reduces the Susceptibility to Phagocytosis by Mouse Macrophages
To determine whether expression of mouse CD47 on rat cells could efficiently prevent their phagocytosis by mouse macrophages, we generated rat insulinoma cell lines that express mouse CD47 by transfecting rat cells with a mouse CD47-expressing plasmid, pRc/CMV-mouse CD47 (Fig. 2A) . Mouse CD47 expression on the transfected INS-1E cells was confirmed by FACS analysis (Fig. 2B) . The expression level of CD47 on the pRc/CMV-mouse CD47 vector-transfected INS-1E cells (mCD47-INS-1E) was higher than that on mouse PBMCs, whereas the control vector-transfected INS-1E (cont-INS-1E) cells tested negative for mouse CD47. We have confirmed constant expression of mouse CD47 on mCD47-INS-1E cells in diabetic Rag2 2/2 c chain 2/2 mice without further G418-selection at least until 8 days after the inoculation. Western blotting revealed that incubation of mouse macrophages with mCD47-INS-1E resulted in significant tyrosine phosphorylation of SIRPa, indicating that mCD47-INS-1E cells functionally interact with mouse SIRPa (Fig. 2C) . Except for functional mouse CD47 expression, mCD47-INS-1E cells were comparable to cont-INS-1E cells with respect to their morphology, proliferation rates, and insulin producing activity (data not shown).
The phagocytic activities of mouse macrophages toward both INS-1E cell lines were evaluated by in vivo assays. CFSE-labeled mCD47-INS-1E or cont-INS-1E cells were injected into the peritoneal cavity of streptozotocin-induced diabetic Rag2 2/2 c chain 2/2 mice, which lack T, B, and NK cells. The recipient intraperitoneal cells were harvested after 6 h, and macrophages that phagocytosed the target cells were then detected as CD11b-and CFSE-double-positive cells, using FACS analysis (Fig. 3A) . The proportion of CFSE + cells among all the CD11b + cells was significantly lower in cells obtained from mCD47-INS-1E recipients than from cont-INS-1E recipients. This result indicated that mouse CD47 expression on rat cells markedly reduced the susceptibility of these cells to phagocytosis by mouse macrophages (Fig. 3B) .
To investigate whether these protections were due to CD47 overexpression or to the species-specific effect of mouse CD47, another line of rat insulinoma cells (mCD47 low -INS-1E) labeled with CFSE, which expressed lower levels of mouse CD47 (MFI 330.67) than the original mCD47-INS-1E cells (MFI 506.88), were injected into the peritoneal cavity of streptozotocin-induced diabetic Rag2 2/2 c chain 2/2 mice. Intraperitoneal cells of the recipients were harvested after 6 h, and macrophages that phagocytosed the target cells were detected using FACS analysis. The proportion of CFSE + cells among all CD11b + cells was significantly lower in cells obtained from mCD47 low -INS-1E recipients than in those from cont-INS-1E recipients. However, no significant difference was observed in phagocytic activity between mCD47-INS-1E recipients and mCD47 low -INS-1E recipients. This result indicated that, in this model, the protection was not simply due to overexpression of mouse CD47 (Fig. 3B ).
Diabetic Rag2
2/2 c chain 2/2 Mice became Normoglycemic after Receiving mCD47-INS-1E
Next, mCD47-INS-1E or cont-INS-1E cells were injected into the peritoneal cavity of Rag2
2/2 c chain 2/2 mice with streptozotocin-induced diabetes; the blood glucose levels of these mice became normoglycemic after receiving mCD47-INS-1E. In contrast, the mice that received cont-INS-1E failed to achieve normoglycemia (Fig. 4) . Thus, the in vivo transplant model proved that genetically engineered expression of mouse CD47 in rat insulinoma cells could inhibit macrophage-mediated xenograft rejection.
CD47-SIRPa Signaling Blockade Prevents the Effects of Mouse CD47 on Macrophage-mediated Xenograft Rejection
We further explored the practical contribution of CD47-SIRPa signaling to the successful engraftment of mCD47-INS-1E xenografts in the diabetic Rag2 2/2 c chain 2/2 mice by using the anti-mouse SIRPa Ab (P84) to block this signaling. Mouse SIRPa, on the peritoneal macrophages of Rag22/2 c chain 2/ 2 mice, had not been decreased and had been capped after the intraperitoneal injection of P84 for at least 8 days (Fig. 5A and B) .
Twenty-four hours after P84 injection, either mCD47-INS-1E or cont-INS-1E cells were injected into the peritoneal cavity of the diabetic Rag2
2/2 c chain 2/2 mice. Irrespective of which cell line recipients received, mice failed to achieve normoglycemia (Fig. 5C ), indicating the essential role of CD47-SIRPa signaling in overcoming macrophage-mediated rejection of xenografts.
CD47-SIRPa Signaling Blockade does not Induce Phagocytosis of Congenic Cells
We further examined whether injection of P84 into the peritoneal cavity of diabetic Rag2 in phagocytosis by mouse cells. Twenty-four hours after injection of either P84 or control antibody, CFSE-labeled congenic T cells were injected into the peritoneal cavity of mice. After 6 h, intraperitoneal cells of the recipients were harvested and mouse macrophages that phagocytosed congenic T cells were then detected as CD11b-and CFSE-double-positive cells using FACS analysis. As shown in Fig. 6 , no significant difference was observed in phagocytic activity between the 2 groups. This result indicated that CD47-SIRPa signaling blockade does not induce phagocytosis of congenic cells.
Discussion
In the present study, genetic induction of the expression of mouse CD47 on rat insulin-producing cells could deliver inhibitory signaling to SIPRa on mouse peritoneal macrophages, preventing rejection of the rat cells during observation periods. It has previously been reported that CD47-SIRPa interactions exhibit limited cross-species reactivity probably because of species-specific posttranslational modifications of CD47 such as glycosylation, i.e. CD47 on pig but not on mouse, cow, or rat RBCs binds the recombinant extracellular dommain of human SIRPa1 [21] . It has been also demonstrated that pig CD47 does not interact with mouse SIRPa [22] . Consistently, the phagocytic synapse at cell contacts has been proven to involve a basal level of actin-driven phagocytosis that is made more efficient by phosphoactivated myosin in the absence of species-specific CD47 signaling [23] . Recently, we have verified that pig CD47 also does not interact with human SIRPa, and, importantly, that genetic manipulation of porcine cells for expression of human CD47 markedly reduces the susceptibility of these cells to phagocytosis by human macrophages in vitro [10] .
Other groups have also shown that functional species-specific CD47/SIRPa interaction is required for generating improved models of mouse/human chimeras: mouse CD47-expression in transplanted human hematopoietic cells is required for optimal human T-and natural killer-cell homeostasis in mice [24] . Furthermore, the introduction of mouse CD47 into primary human hepatocytes confers a positive selective advantage upon engraftment into the mouse liver in vivo [25] . Currently available data from in vivo experiments assessing xenograft survival indicates that CD47 provides a potential molecular target for inhibiting macrophage-mediated rejection of xenogeneic cells. Hence, this suggests the necessity of establishing human CD47-transgenic pigs as clinically applicable donors of xenografts.
It is well known that innate immune responses mediated by monocytes/macrophages can drive and shape the process of adaptive immunity. Phagocytic activities of macrophages form a first line of defense against invading infectious microbes, and these macrophages can present antigens derived from such phagocytosed foreign pathogens to T cells. It is likely that these mechanisms also take place in xenotransplantation from phylogenetically distant species. Therefore, specific elimination of phagocytic activity of host macrophages toward xenogeneic cells by genetically inducing host-type CD47 expression may also attenuate subsequent T cell immune responses against xenoantigens, while maintaining normal responses against other pathogens.
It has also been reported that a similar CD47-SIRP system negatively regulates the functions of both T cells and APCs in humans [14] . In contrast, it has been demonstrated that the interaction between CD47 on APCs and SIRPc (also known as SIRPb2) on T cells promotes the proliferation of antigen-specific T cells and co-stimulates T cell activation [26] . These observations raise a question as to whether interspecies incompatibility of CD47 affects CD4+ T cell-mediated responses to xenoantigens positively or negatively. In our previous study, recombinant human CD47-Fc fusion protein (which contains the extracellular domain of human CD47 fused to the Fc portion of human immunoglobulin) significantly reduced the indirect response of human CD4+ T cells to porcine antigens, but did not affect the direct response of these cells in in vitro pig-to-human mixed lymphocyte reaction assays [27] . Inhibition of the phagocytic activity of human APCs toward porcine cells by interaction between the human CD47-Fc fusion protein and the corresponding ligand, probably SIRPa, might might attenuate subsequent CD4+ T cell immune responses against porcine antigens. Taking into consideration that SIRPc binds CD47 with a lower affinity (KD: about 23 mM) than SIRPa (KD: about 2 mM) [28] , the interaction between human CD47-Fc and SIRPc on human CD4+ T cells conferring direct xenospecificity may might not affect CD4+ T cell immune responses. Unlike this in vitro system, however, if human CD47 molecules are highly expressed on porcine APCs by genetic manipulations, there will be a risk that CD4+ T cell-mediated responses to xenoantigens are promoted. These possibilities should be addressed in further studies employing an immunocompetent animal model enabling long-term observation. In that particular case, the model utilizing rat inslinoma in mice would not be suitable, since the mouse recipients of mCD47-INS-1E cells in this study eventually died from hypoglycemia due to growth of the inocula. Further studies are needed for long-term observation employing a rat CD47-transfected normal mouse islet model.
It has been reported that the ability of glucocorticoids to promote macrophage phagocytosis of CD47-deficient targets could, in part, be mediated by an upregulation of expression of LDL receptor-related protein-1 (LRP1/CD91/a2-macroglobulin receptor) macrophages [29] . Since glucocorticoids are indispensable in immunosuppressive therapy after xenogeneic or even allogeneic cellular/organ transplantation, glucocorticoid-treated macrophages may enhance phagocytosis of xenogeneic cells. Therefore, genetic manipulation of xenogeneic cells for host-type CD47 expression would be particularly useful to reduce the likelihood of phagocytosis by macrophages.
It has been recently demonstrated that CD47 is a molecule commonly expressed on neoplastic cells. Its function to block phagocytosis is known, and blockade of this function leads to tumor cell phagocytosis and elimination [30, 31] . Consistently, in a separate experiment, we also observed that insulinoma cell function in a syngeneic model depends on SIRPa-mediated inhibition of macrophages through engagement with its ligand CD47, i.e., treatment with anti-SIRPa Abs enhanced macrophage-mediated elimination of mouse insulinoma cells in diabetic Rag2 2/2 c chain 2/2 mice (data not shown). It remains to be elucidated whether the observations made in neoplastic cells in this study apply to normal xenografts. However, together with our previous in vitro finding that genetic induction of human CD47 on porcine non-neoplastic lymphoblastoid cells radically reduced the susceptibility of those cells to phagocytosis by human macrophages, our results of the present study may lead to the development of approaches for attenuating macrophage-mediated xenograft rejection by genetic manipulation of porcine cells for human CD47 expression.
In conclusion, we have here demonstrated that interspecies incompatibility of CD47 significantly contributes to in vivo rejection of xenogeneic cells by macrophages. Our results imply that genetic induction of recipient CD47 on xenogeneic donor cells could provide inhibitory signals to recipient macrophages via SIPRa; this constitutes a novel approach to prevent macrophagemediated xenograft rejection.
